Laurus Labs receives approval from USFDA for Tenofovir Disoproxil Fumarate Tablets

01 Dec 2017 Evaluate

Laurus Labs has received its maiden tentative approval from United States Food and Drug Administration (USFDA) for Tenofovir Disoproxil Fumarate Tablets 300mg. Tenofovir Disoproxil Fumarate Tablets 300mg is therapeutically equivalent to VIREAD Tablets 300mg of Gilead Science (GILEAD). Tenofovir Disoproxil Fumarate Tablets 300mg is used for treatment of HIV-1 infection in adults and paediatric patients 2 years of age and older.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.


Laurus Labs Share Price

605.95 19.15 (3.26%)
19-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1733.45
Dr. Reddys Lab 1171.90
Cipla 1498.50
Lupin 2060.70
Zydus Lifesciences 909.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...